Nihon Kohden Corp (NHNKY)
13.98
-0.14
(-0.97%)
USD |
OTCM |
Jun 27, 16:00
Nihon Kohden Enterprise Value: 2.017B for June 27, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 27, 2024 | 2.017B |
| June 26, 2024 | 2.040B |
| June 25, 2024 | 2.145B |
| June 24, 2024 | 2.142B |
| June 21, 2024 | 2.070B |
| June 20, 2024 | 2.194B |
| June 18, 2024 | 2.201B |
| June 17, 2024 | 2.191B |
| June 14, 2024 | 2.144B |
| June 13, 2024 | 2.141B |
| June 12, 2024 | 2.217B |
| June 11, 2024 | 2.188B |
| June 10, 2024 | 2.122B |
| June 07, 2024 | 2.194B |
| June 06, 2024 | 2.185B |
| June 05, 2024 | 2.275B |
| June 04, 2024 | 2.234B |
| June 03, 2024 | 2.236B |
| May 31, 2024 | 2.171B |
| May 30, 2024 | 2.165B |
| May 29, 2024 | 2.083B |
| May 28, 2024 | 2.223B |
| May 24, 2024 | 2.089B |
| May 23, 2024 | 2.042B |
| May 22, 2024 | 2.041B |
| Date | Value |
|---|---|
| May 21, 2024 | 2.037B |
| May 20, 2024 | 2.023B |
| May 17, 2024 | 2.034B |
| May 16, 2024 | 2.026B |
| May 15, 2024 | 1.979B |
| May 14, 2024 | 2.037B |
| May 13, 2024 | 2.125B |
| May 10, 2024 | 2.003B |
| May 09, 2024 | 2.000B |
| May 08, 2024 | 1.973B |
| May 07, 2024 | 1.978B |
| May 06, 2024 | 2.065B |
| May 03, 2024 | 2.038B |
| May 02, 2024 | 2.009B |
| May 01, 2024 | 1.974B |
| April 30, 2024 | 1.992B |
| April 29, 2024 | 1.940B |
| April 26, 2024 | 1.969B |
| April 25, 2024 | 1.934B |
| April 24, 2024 | 1.964B |
| April 23, 2024 | 1.932B |
| April 22, 2024 | 1.922B |
| April 19, 2024 | 1.883B |
| April 18, 2024 | 1.872B |
| April 17, 2024 | 1.860B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.243B
Minimum
Jun 21 2022
3.078B
Maximum
Mar 30 2020
2.028B
Average
2.029B
Median
Aug 28 2019
Enterprise Value Benchmarks
| Takeda Pharmaceutical Co Ltd | 69.40B |
| Nxera Pharma Co Ltd | 983.06M |
| PeptiDream Inc | 1.815B |
| Healios KK | 83.01M |
| AnGes Inc | 59.01M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 61.31M |
| Revenue (Quarterly) | 443.46M |
| Total Expenses (Quarterly) | 382.31M |
| EPS Diluted (Quarterly) | 0.3647 |
| Gross Profit Margin (Quarterly) | 50.24% |
| Profit Margin (Quarterly) | 13.83% |
| Earnings Yield | 5.00% |
| Operating Earnings Yield | 5.71% |
| Normalized Earnings Yield | 4.188 |